Welcome to the International League Against Epilepsy
The World's preeminent association of health care professionals and scientists working toward a world where no person's life is limited by epilepsy
Please take a few minutes to complete the new survey and share it with your colleagues. The survey looks at current treatment practices in 6 typical early life epilepsy scenarios. Our aim is not only to show first and second line treatment preferences, but also to illustrate that we commonly use off-label drugs in childhood epilepsies.
9 September, 2020
More than one-third of people with chronic epilepsy in rural China have potentially epileptogenic lesions identifiable on brain MRI, with two-thirds fulfilling the definition of pharmacoresistance. These findings highlight the magnitude of the unmet needs for epilepsy surgery in China.
17 September, 2020
Epileptic Disorders is pleased to announce that Alexis Arzimanoglou is now Editor-in-Chief Emeritus and Elza Márcia Yacubian was named Deputy Editor. Sándor Beniczky remains Editor-in-Chief.
7 September, 2020
This paper reviews recent evidence from human and experimental models of absence seizures and concludes that “Together, these novel clinical and experimental findings bring about paradigm-shifting views of our understanding of absence seizures and demand careful choice of initial monotherapy and continuous neuropsychiatric evaluation of affected children”
31 August, 2020
The International League Against Epilepsy disseminates the latest original research findings and breakthroughs in the cure for epilepsy and related seizure disorders through its official peer-reviewed publications.
Ravish Keni, Barbara Mostacci, Gordana Kiteva-Trenchevska, Laura Licchetta, Liljana Ignjatova, Sanjeev Thomas, Kimford J. Meador
10 August - 5 October 2020
24 September - 4 October 2020
Chalfont St Peter, UK
8 - 10 October 2020
13 - 16 October 2020
15 October 2020
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community